A Bruton's Tyrosine Kinase Inhibitor Prevents Antigen-Driven B Cell Activation In Vivo

被引：0

作者：

Benson, Micah ^{[1
]}

Rodriguez, Varenka A. ^{[1
]}

Andreyeva, Tatyana ^{[1
]}

Keegan, Sean ^{[1
]}

Springer, John R. ^{[1
]}

Schnute, Mark E. ^{[1
]}

Dunussi-Joannopoulos, Kyri ^{[1
]}

Nickerson-Nutter, Cheryl L. ^{[1
]}

Rankin, Andrew L. ^{[1
]}

Ruzek, Melanie ^{[1
]}

Douhan, John, III ^{[1
]}

机构：

[1] Pfizer Inc, Cambridge, MA USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1758

引用

页码：S689 / S689

页数：1

共 50 条

[31] Functional role of Bruton′s tyrosine kinase inhibitor therapy in the tumor microenvironment of B-cell malignancies
Barbarino, V.
Henschke, S.
Blakemore, S. J.
Nickel, N.
Vorholt, D.
Hallek, M.
Pallasch, C.
ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 220 - 221
[32] Bruton's tyrosine kinase couples NF-κB to the B cell receptor
Petro, JB
Rahman, SMJ
Khan, WN
FASEB JOURNAL, 2000, 14 (06): : A929 - A929
[33] Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Woyach, Jennifer A.
Furman, Richard R.
Liu, Ta-Ming
Ozer, Hatice Gulcin
Zapatka, Marc
Ruppert, Amy S.
Xue, Ling
Li, Daniel Hsieh-Hsin
Steggerda, Susanne M.
Versele, Matthias
Dave, Sandeep S.
Zhang, Jenny
Yilmaz, Ayse Selen
Jaglowski, Samantha M.
Blum, Kristie A.
Lozanski, Arletta
Lozanski, Gerard
James, Danelle F.
Barrientos, Jacqueline C.
Lichter, Peter
Stilgenbauer, Stephan
Buggy, Joseph J.
Chang, Betty Y.
Johnson, Amy J.
Byrd, John C.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (24): : 2286 - 2294
[34] Novel leflunomide analog inhibitor of Bruton's tyrosine kinase
Mahajan, S
Ghosh, S
Sudbeck, E
Zheng, YG
Downs, S
Uckun, FM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U283 - U283
[35] Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells
Feldhahn, N
Rio, P
Soh, BNB
Liedtke, S
Sprangers, M
Klein, F
Wernet, P
Jumaa, H
Hofmann, WK
Hanenberg, H
Rowley, JD
Müschen, M
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (37) : 13266 - 13271
[36] Targeting Bruton’s Tyrosine Kinase Across B-Cell Malignancies
Caspar da Cunha-Bang
Carsten Utoft Niemann
Drugs, 2018, 78 : 1653 - 1663
[37] Deficiency of Bruton's tyrosine kinase in B cell precursor leukemia cells
不详
IMMUNOBIOLOGY, 2005, 210 (6-8) : 462 - 462
[38] Targeting Bruton's Tyrosine Kinase Across B-Cell Malignancies
da Cunha-Bang, Caspar
Niemann, Carsten Utoft
DRUGS, 2018, 78 (16) : 1653 - 1663
[39] The Evolving Role of Bruton's Tyrosine Kinase Inhibitors in B Cell Lymphomas
Mehra, Shefali
Nicholls, Miah
Taylor, Justin
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
[40] Involvement of Bruton's tyrosine kinase (BTK) in CD38-mediated B cell activation.
Yasue, T
Kikuchi, Y
Nishizumi, H
Miyake, K
Yamamoto, T
Takatsu, K
FASEB JOURNAL, 1996, 10 (06): : 381 - 381

← 1 2 3 4 5 →